Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

Shira Avigona says 'private' in private science refers to where work happens, not funding source: not universities or government national labs. Bell Labs and Xerox PARC declined after their corporate parents lost monopolies and patents, so new nonprofits and standalone institutes are testing different structures.

Related Insights

AI firms brand themselves as "labs" to sound like non-profit research entities, a rhetorical move to shirk the responsibilities and product liability standards applied to for-profit corporations. This tactic is compared to the lack of accountability from the Wuhan lab.

Shira Avigona says the White House science office explicitly endorsed new private science models, and the National Science Foundation plans $1.5bn for X labs. She worries this puts them in competition with university science, which the federal government has long funded, whether advocates intended it or not.

The "Genesis Mission" aims to use national labs' data and supercomputers for AI-driven science. This initiative marks a potential strategic shift away from the prevailing tech belief that breakthroughs like AGI will emerge exclusively from private corporations, reasserting a key role for government-led R&D in fundamental innovation.

Nonprofits occupy a unique space. While academia pursues discovery and industry seeks revenue, nonprofits can fund "infrastructure" projects like large, open-access datasets. These efforts accelerate the entire ecosystem, a goal neither academia nor industry is incentivized to pursue alone.

Scientific progress requires more than just papers that lead to tenure. It also needs tool-building, software development, and connecting disparate ideas. These activities are valuable for science but often undervalued by academic incentive structures, creating an opportunity for new institutions to fill the gap.

Small, independent AI labs ("Neo-labs") are not genuine competitors to frontier players like OpenAI. Instead, they serve as a career interlude for high-profile researchers. These individuals can raise capital, enjoy a secondary liquidity event, and work on passion projects before ultimately being re-absorbed into a major lab.

The foundational U.S. science policy was created in 1945 when the government funded 70% of all R&D. Today, that ratio has inverted, with industry funding 70%. This dramatic shift requires a new government strategy focused on funding only the basic, pre-competitive research that the private sector won't.

CZI focuses on creating new tools for science, a 10-15 year process that's often underfunded. Instead of just giving grants, they build and operate their own institutes, physically co-locating scientists and engineers to accelerate breakthroughs in areas traditional funding misses.

CZI strategically focuses on developing long-term scientific tools and platforms by operating its own labs. This addresses a funding gap left by government grants for individual investigators and public-health-focused philanthropies, aiming to accelerate research for all scientists.

Vannevar Bush's pivotal idea was a system where the federal government funds research, but the work is executed in private university and industrial labs. This decentralized model harnessed existing ingenuity, contrasting with a model where scientists worked directly for the military or government-run institutions.